News Archive

2019

January

compact_imaging_eye_diseases_AMD_diabetic_retinopathy_age-related_macular_degeneration
Story / Jan 22, 2019

Novartis Signs Collaboration Agreement to Fund Medtech Development of Low Cost Eye Monitor

Read More
2018

November

Story / Nov 16, 2018

European Patient Innovation Summit 2018

Read More
Story / Nov 09, 2018

Novartis Post-Budget Breakfast Meeting

Read More

October

Media Release / Oct 11, 2018

Sandoz announces global resolution of biosimilar adalimumab patent disputes, securing patient access

Read More
Media Release / Oct 10, 2018

Novartis announces new data from the first direct head-to-head trial to demonstrate superior efficacy of Gilenya® over Copaxone® in patients with relapsing remitting multiple sclerosis

Read More
Media Release / Oct 10, 2018

Breadth of data at ECTRIMS underpins Novartis' relentless commitment to decoding the science of multiple sclerosis (MS) and decreasing the patient burden

Read More
Media Release / Oct 09, 2018

Novartis analysis shows crizanlizumab (SEG101) increased the number of patients free of sickle cell pain crises vs placebo during SUSTAIN study

Read More
Media Release / Oct 08, 2018

Novartis announces FDA and EMA filing acceptance of siponimod, the first and only drug shown to meaningfully delay disability progression in typical SPMS patients

Read More
Media Release / Oct 04, 2018

Sandoz Healthcare Access Challenge (HACk) returns, seeking digital solutions to local healthcare access challenges

Read More
Media Release / Oct 03, 2018

Novartis licenses three novel anti-infective programs to Boston Pharmaceuticals

Read More

Pages

Related Links